Skip to main content
倍益康 logo

倍益康 — Investor Relations & Filings

Ticker · 920199 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 360 across all filing types
Latest filing 2023-01-08 Transaction in Own Shar…
Country CN China
Listing Beijing Stock Exchange 920199

About 倍益康

https://www.qlbeoka.com/

Beiyikang focuses on the research, development, and manufacturing of rehabilitation and physical therapy equipment. The company integrates professional medical technology with consumer-oriented health solutions. Its product lineup features percussive massage devices, oxygen concentrators, blood pressure monitors, and specialized physical therapy instruments for pain relief and muscle recovery. By utilizing advanced manufacturing processes and technological innovation, Beiyikang delivers products for sports recovery, clinical rehabilitation, and personal health management. The company prioritizes the incorporation of smart technology into its hardware to improve therapeutic outcomes and user experience across its range of recovery and wellness devices.

Recent filings

Filing Released Lang Actions
回购股份方案公告
Transaction in Own Shares Classification · 100% confidence The document is a detailed announcement regarding a company's share repurchase plan, including the purpose, method, price, quantity, funding source, implementation period, and impact on the company's financial status and shareholding structure. It also includes management analysis and authorization details for the repurchase. The content focuses on the company's plan to buy back its own shares and related procedural and regulatory compliance information. There is no indication that this is a full financial report, earnings release, or other types of filings such as management changes or voting results. The document fits the definition of a Transaction in Own Shares (POS) filing, which covers announcements of share repurchase activities.
2023-01-08 Chinese
关于实施稳定股价方案的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement from Sichuan Qianli Beiyikang Medical Technology Co., Ltd. regarding the implementation of a stock price stabilization plan involving share repurchases. It details the conditions triggering the plan, the repurchase method, funding, limits, and the impact on shareholding structure. The document is relatively short (2645 characters) and focuses on a specific capital action (share repurchase) to stabilize stock price. It is not a full financial report, earnings release, or management discussion. It is not a regulatory certification or a report publication announcement. The content fits best under the category of Transaction in Own Shares (POS), which covers company buyback or sale of its own shares.
2023-01-08 Chinese
第三届董事会第九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the ninth meeting of the third board of directors of Sichuan Qianli Beiyikang Medical Technology Co., Ltd. It includes information about meeting attendance, agenda items, voting results, and references to other announcements related to stock repurchase, capital changes, and financing. The content focuses on board decisions and governance matters rather than financial results or reports. It is not a full annual or interim report, nor an earnings release or audit report. The document is a formal board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is 4273 characters, which is sufficient for a detailed board meeting resolution notice rather than a brief announcement or report publication notice.
2023-01-08 Chinese
关于修订信息披露管理制度的公告
Board/Management Information Classification · 95% confidence The document is an announcement from Sichuan Qianli Beiyikang Medical Technology Co., Ltd. regarding the revision of its "Information Disclosure Management System." It details changes approved by the board of directors and mentions submission to the shareholders' meeting for approval. The content focuses on governance and disclosure procedures rather than financial results or reports. The document length is short (1144 characters), and it is not a full report but an announcement of internal governance changes. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes in company management or board-related policies.
2023-01-08 Chinese
关于使用闲置自有资金购买理财产品的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Sichuan Qianli Beiyikang Medical Technology Co., Ltd. regarding the use of idle funds to purchase financial products. It includes details about the purpose, amount, risk analysis, and board approval of the investment. The document is a formal announcement of a financing activity related to the company's capital management but does not contain financial statements or detailed financial results. It is not a full financial report, earnings release, or regulatory filing. The content fits best under Capital/Financing Update (CAP) as it informs about the company's financing activity involving investment of idle funds in financial products.
2023-01-08 Chinese
关于接待机构投资者调研情况的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the reception of an institutional investor research visit, detailing questions and answers about the company's products, R&D progress, market outlook, and financial data related to R&D expenses. It is not a full financial report, earnings release, or regulatory filing. The document is relatively short (2665 characters) and serves as a disclosure of investor relations activity rather than a formal report or announcement of voting results, management changes, or capital changes. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. The content is primarily about investor communication and company updates during a research visit, which aligns best with a Regulatory Filings (RNS) classification as a general regulatory announcement that does not fit other specific categories.
2022-12-26 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.